SEC Form 4 · accession 0000899243-18-001188
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gillian C Ivers-Read
Officer — See Remarks
Period of report
Jan 16, 2018
Accepted (ET)
Jan 17, 2018 · 4:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 16, 2018 | S | 3,000 | $59.16 | D | 183,571 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 6, 2017.
Remarks
Executive Vice President of Technical Operations and Chief Regulatory Officer